Repligen
RGEN
#2090
Rank
โ‚น948.83 B
Marketcap
โ‚น16,813
Share price
-3.16%
Change (1 day)
56.16%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): โ‚น6.91 Billion

According to Repligen 's latest financial reports the company's current earnings are โ‚น0.76 Billion. In 2025 the company made an earning of โ‚น8.00 Billion, an increase over its 2024 earnings that were of -โ‚น0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น6.91 B-13.55%
2025 โ‚น8.00 B-1430.84%
2024 -โ‚น0.61 Billion-113.01%
2023 โ‚น4.62 B-78.01%
2022 โ‚น21.01 B33.37%
2021 โ‚น15.75 B131.52%
2020 โ‚น6.80 B101.31%
2019 โ‚น3.38 B25.93%
2018 โ‚น2.68 B105.61%
2017 โ‚น1.30 B-11.46%
2016 โ‚น1.47 B14.91%
2015 โ‚น1.28 B20.26%
2014 โ‚น1.06 B-51.49%
2013 โ‚น2.19 B90.98%
2012 โ‚น1.15 B
2010 โ‚น16.69 M-103.81%
2009 -โ‚น0.44 Billion-223.84%
2008 โ‚น0.35 B
2006 -โ‚น0.24 Billion229.64%
2005 -โ‚น72 Million-89.16%
2004 -โ‚น0.67 Billion-16.86%
2003 -โ‚น0.8 Billion88.72%
2002 -โ‚น0.43 Billion-27.88%
2001 -โ‚น0.59 Billion-1.74%
2000 -โ‚น0.6 Billion85.93%
1999 -โ‚น0.33 Billion159.16%
1998 -โ‚น0.13 Billion85.71%
1997 -โ‚น66.77 Million-70.83%
1996 -โ‚น0.23 Billion-72.41%
1995 -โ‚น0.83 Billion-60.63%
1994 -โ‚น2.11 Billion45.39%
1993 -โ‚น1.45 Billion39.45%
1992 -โ‚น1.04 Billion-32.3%
1991 -โ‚น1.54 Billion6.62%
1990 -โ‚น1.45 Billion1577.78%
1989 -โ‚น85.85 Million-57.14%
1988 -โ‚น0.21 Billion-362.5%
1987 โ‚น76.3 M-130.77%
1986 -โ‚น0.25 Billion136.36%
1985 -โ‚น0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.010 T 13,468.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น707.91 B 9,408.92%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.092 T 14,569.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น915.36 B 12,195.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น10.53 Billion-241.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น6.15 Billion-182.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น76.18 B 923.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น14.95 B 100.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.77 B 394.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚น15.78 Billion-311.94%๐Ÿ‡บ๐Ÿ‡ธ USA